[{"type": "title", "data": "LTC COVID - 19 Symptom Management and Therapeutics"}, {"type": "category", "data": "Status"}, {"type": "note", "data": "To be initiated at the time of COVID-19 diagnosis in the LTC resident, where supportive / therapeutic   measures are desired. Should comfort measures only be desired, or when end-of-life care is the primary goal, use the Long-Term Care Facility Comfort Care Orders for COVID-19", "value": ""}, {"type": "note", "data": "Goals of Treatment:  Ensure adequate oxygenation and hemodynamic support during acute phase of illness  Prevent complications where possible (e.g. thrombosis)  Prevent unnecessary transfer to acute care", "value": ""}, {"type": "note", "data": "Monitor resident clinical status, symptoms, and comfort twice per shift", "value": ""}, {"type": "sentence", "data": "None"}, {"type": "category", "data": "Patient Care"}, {"type": "order", "data": "Patient Isolation", "value": ""}, {"type": "sentence", "data": "T;N, Droplet and Contact, COVID-19, use appropriate eye protection"}, {"type": "order", "data": "Vital Signs", "value": ""}, {"type": "sentence", "data": "T;N, BID, and as clinically required"}, {"type": "order", "data": "Pulse Oximetry", "value": ""}, {"type": "sentence", "data": "T;N, BID, and as clinically required"}, {"type": "order", "data": "Oxygen Therapy", "value": ""}, {"type": "sentence", "data": "T;N, Titrate O2 to keep SpO2 92% or greater, Maximum 6 L/min, Nasal Cannula, SpO2 88 to 92% for diagnosed COPD"}, {"type": "category", "data": "Medications"}, {"type": "note", "data": "Acute Symptom Management", "value": ""}, {"type": "note", "data": "If on O2 at 6 L/min via nasal prongs and resident unable to maintain oxygen saturation greater than 92%, continue O2 at 6 L/min and start medications to support comfort with shortness of breath", "value": ""}, {"type": "order", "data": "dextromethorphan", "value": ""}, {"type": "sentence", "data": "15 mg, PO, q4h, PRN cough, drug form: oral liq"}, {"type": "order", "data": "HYDROmorphone PRN range dose", "value": ""}, {"type": "sentence", "data": "dose range: 0.5 to 1 mg, PO, q4h, PRN other (see comment), drug form: tab"}, {"type": "order", "data": "HYDROmorphone PRN range dose", "value": ""}, {"type": "sentence", "data": "dose range: 0.25 to 0.5 mg, subcutaneous, q4h, PRN other (see comment), drug form: inj"}, {"type": "order", "data": "acetaminophen PRN range dose", "value": ""}, {"type": "sentence", "data": "dose range: 325 to 650 mg, PO, q6h, PRN pain-mild or fever, drug form: tab"}, {"type": "order", "data": "acetaminophen PRN range dose", "value": ""}, {"type": "sentence", "data": "dose range: 325 to 650 mg, rectal, q6h, PRN pain-mild or fever, drug form: supp"}, {"type": "order", "data": "dimenhyDRINATE PRN range dose", "value": ""}, {"type": "sentence", "data": "dose range: 25 to 50 mg, PO, q6h, PRN nausea or vomiting, drug form: tab"}, {"type": "order", "data": "dimenhyDRINATE PRN range dose", "value": ""}, {"type": "sentence", "data": "dose range: 25 to 50 mg, rectal, q6h, PRN nausea or vomiting, drug form: supp"}, {"type": "order", "data": "dimenhyDRINATE PRN range dose", "value": ""}, {"type": "sentence", "data": "dose range: 25 to 50 mg, subcutaneous, q6h, PRN nausea or vomiting, drug form: inj"}, {"type": "order", "data": "LORazepam PRN range dose", "value": ""}, {"type": "sentence", "data": "dose range: 0.5 to 1 mg, sublingual, q4h, PRN anxiety, drug form: tab-sublingual"}, {"type": "note", "data": "Dexamethasone is indicated for residents who are hypoxic requiring O2 supplementation secondary to COVID-19", "value": ""}, {"type": "order", "data": "dexamethasone", "value": ""}, {"type": "sentence", "data": "6 mg, PO, qdaily, order duration: 10 day, drug form: tab"}, {"type": "order", "data": "dexamethasone", "value": ""}, {"type": "sentence", "data": "6 mg, subcutaneous, qdaily, order duration: 10 day, drug form: inj"}, {"type": "note", "data": "Antibiotics are not recommended for residents with COVID-19 who do not require supplemental oxygen.  Consider antibiotics if suspected bacterial co-infection, rapidly increasing supplemental oxygen requirements, or evidence of sepsis", "value": ""}, {"type": "order", "data": "amoxicillin-clavulanate 875 mg-125 mg tab (dosed as amoxicillin)", "value": ""}, {"type": "sentence", "data": "875 mg, PO, BID, order duration: 5 day, drug form: tab"}, {"type": "note", "data": "If eGFR less than 30 mL/min", "value": ""}, {"type": "order", "data": "amoxicillin-clavulanate 500 mg-125 mg tab (dosed as amoxicillin)", "value": ""}, {"type": "sentence", "data": "500 mg, PO, BID, order duration: 5 day, drug form: tab"}, {"type": "note", "data": "Add azithromycin if atypical bacterial causes of pneumonia (e.g. mycoplasma chlamydophila) are strongly suspected. Caution if prolonged QTc.", "value": ""}, {"type": "order", "data": "azithromycin", "value": ""}, {"type": "sentence", "data": "500 mg, PO, qdaily, order duration: 3 day, drug form: tab"}, {"type": "note", "data": "For severe penicillin allergy (e.g. anaphylaxis)", "value": ""}, {"type": "order", "data": "MOXIfloxacin", "value": ""}, {"type": "sentence", "data": "400 mg, PO, qdaily, order duration: 5 day, drug form: tab"}, {"type": "note", "data": "Offer plenty of fluids as frequently as tolerated PRN. If unable to take adequate oral fluid x 24 hours, consider initiating hypodermoclysis", "value": ""}, {"type": "sentence", "data": "None"}, {"type": "sub phase", "data": "LTC Hypodermoclysis (Module)", "value": ""}, {"type": "sentence", "data": "None"}, {"type": "note", "data": "For residents whom are severely ill with COVID-19, consider DVT prophylaxis", "value": ""}, {"type": "sub phase", "data": "Venous Thromboembolism (VTE) Prophylaxis - Medicine (Module)", "value": ""}, {"type": "sentence", "data": "None"}]
